163 related articles for article (PubMed ID: 2575179)
1. Blood pressure and lipid lowering effects of terazosin.
Rosenthal J
J Hum Hypertens; 1989 Dec; 3 Suppl 2():85-9; discussion 90-1. PubMed ID: 2575179
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral antihypertensive agents on blood lipid levels.
Leren P
Clin Ther; 1986; 8(3):309-19. PubMed ID: 2872961
[TBL] [Abstract][Full Text] [Related]
4. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
5. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha 1-blockers in combination therapy for hypertension.
Zusman RM
Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
Kincaid-Smith P
J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
[TBL] [Abstract][Full Text] [Related]
8. The value of alpha-blockers in the management of hypertension: a practical view.
McInnes GT
J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
[No Abstract] [Full Text] [Related]
9. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.
Shionoiri H; Gotoh E; Ito T; Hata T; Iwatsubo H; Takegawa K; Ogihara T; Mikami H; Ikegami H; Otsuka A
Am J Med Sci; 1994 Feb; 307 Suppl 1():S91-5. PubMed ID: 7908168
[TBL] [Abstract][Full Text] [Related]
10. The relationship between terazosin dose and blood pressure response in hypertensive patients.
Achari R; Hosmane B; Bonacci E; O'Dea R
J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
[TBL] [Abstract][Full Text] [Related]
11. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P
Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632
[TBL] [Abstract][Full Text] [Related]
12. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H
Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of doxazosin: a review.
Brown MJ
J Hum Hypertens; 1990 Oct; 4 Suppl 3():34-8. PubMed ID: 2148193
[TBL] [Abstract][Full Text] [Related]
14. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
15. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
16. The emerging problem of plasma lipid changes during antihypertensive therapy.
Johnson BF
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
[TBL] [Abstract][Full Text] [Related]
17. [Pressure and metabolic effects of terazosin in essential hypertension].
Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drug therapy and coronary heart disease risk.
Schoenberger JA
J Fam Pract; 1993 Jan; 36(1):70-3, 77-84. PubMed ID: 8419507
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and CHD risk: whither alpha-1 blockers?
Pandit RB
Indian Heart J; 1996; 48(3):265-71. PubMed ID: 8755013
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.
Pasanisi F; Imperatore G; Vaccaro O; Iovine C; Ferrara LA
Nutr Metab Cardiovasc Dis; 1999 Apr; 9(2):73-7. PubMed ID: 10726112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
